ERBB2 and breast carcinoma: Here, we focused on understanding whether two types of breast cancer brain metastasis mouse models from the literature as well as a third, new model created in this study provide impaired drug delivery to brain metastases like what is observed for patients with HER2‐positive, metastatic breast cancer.